Since its inception, TAVR has been one of the most exciting innovations in cardiovascular services. In recent years, TAVR has seen significant clinical advancements, leading both to better quality outcomes, and to opportunities for structural heart programs to become more efficient and cost-effective.
Indeed, with TAVR's burgeoning growth and positive forecasts for future volumes, achieving these dual aims of enhanced efficiency and high-quality outcomes will be imperative for structural heart programs to succeed.
Create your free account to access 1 resource, including the latest research and webinars.
You have 1 free members-only resource remaining this month.
1 free members-only resources remaining
1 free members-only resources remaining
You've reached your limit of free insights
Never miss out on the latest innovative health care content tailored to you.
You've reached your limit of free insights
Never miss out on the latest innovative health care content tailored to you.
This content is available through your Curated Research partnership with Advisory Board. Click on ‘view this resource’ to read the full piece
Email ask@advisory.com to learn more
Never miss out on the latest innovative health care content tailored to you.
This is for members only. Learn more.
Never miss out on the latest innovative health care content tailored to you.